Christopher M. Lauderback

Christopher Lauderback is currently the Vice President at KemPharm, Inc. Christopher previously held positions such as Senior Manager, CMC at Sigma-Tau Pharmaceuticals, Inc., Director of Product Development at Airbase Therapeutics, LLC, and Associate Director, CMC Development at New River Pharmaceuticals, which was later purchased by Shire. Prior to that, Christopher also worked as a Senior Scientist at New River Pharmaceuticals.